JM Zarit, 2006 - books.google.com For our parents— Sara R. and Albert Zarit Avis E. and Laurence A. Maes ...
About the Authors Steven H. Zarit, PhD, is Professor and Head of the Department
of Human Development and Family Studies at Pennsylvania State University, ... Cited by 135 - Related articles - All 7 versions
DL Sparks, M Sabbagh, D Connor, H Soares, J … - ACTA NEUROLOGICA SCANDINAVICA …, 2006 - interscience.wiley.com Previous studies have suggested that statin therapy may be of benefit in
treating Alzheimer's disease (AD). We initiated a double-blind,
placebo-controlled, randomized (1:1) trial with a 1-year exposure to ... Cited by 45 - Related articles - BL Direct - All 4 versions
GC Román - Cerebrovasc Dis, 2005 - content.karger.com Brain injury from ischemic or hemorrhagic cerebrovascular disease (CVD) produces
decline in cognitive functions and vascular dementia (VaD). Likewise, CVD may
cause VaD from hypoperfusion of susceptible brain areas. CVD may also ... Cited by 45 - Related articles - BL Direct - All 6 versions
G McGwin, A Xie, C Owsley - Ophthalmology, 2005 - Elsevier The Atherosclerosis Risk in Communities study is a prospective,
population-based, cohort study conducted in 4 communities across the United
States. A total of 15792 individuals aged 45 to 65 years were enrolled ... Cited by 27 - Related articles - All 11 versions
- ►bentham.org [PDF] X Han - Current Alzheimer Research, 2005 - ingentaconnect.com Abstract: Lipids have many important yet distinct functions in cellular
homeostasis such as forming an impermeable barrier separating intracellular and
extracellular compartments, providing a matrix for the appropriate ... Cited by 28 - Related articles - BL Direct - All 6 versions
WJ Lukiw, M Pappolla, RP Pelaez, NG Bazan - Cellular and molecular neurobiology, 2005 - Springer SUMMARY 1. Strong etiological association exists between dysfunctional
metabolism of brain lipids, age-related changes in the cerebral vasculature and
neurodegenerative features char- acteristic of Alzheimer's disease (AD) ... Cited by 24 - Related articles - All 5 versions
TL Spires, AJ Hannan - FEBS Journal, 2005 - huntington-assoc.com Page 1. REVIEW ARTICLE Nature, nurture and neurology: gene–environment
interactions in neurodegenerative disease FEBS Anniversary ... Cited by 20 - Related articles - View as HTML - All 2 versions
RK Gopalraj, H Zhu, JF Kelly, M Mendiondo, … - Neurobiology of aging, 2005 - Elsevier The low density lipoprotein receptor (LDLR) is an attractive candidate gene for
genetic association with Alzheimer's disease (AD) because: (i) the LDLR is an
apolipoprotein E (apoE) receptor, alleles of which have been associated ... Cited by 17 - Related articles - All 5 versions
- ►nih.gov H Xiong, D Callaghan, A Jones, DG Walker, LF … - Neurobiology of disease, 2007 - Elsevier Alzheimer's disease (AD) is characterized by overproduction of Aβ derived from
APP cleavage via β- and γ-secretase pathway. Recent evidence has linked
altered cholesterol metabolism to AD pathogenesis. In this study, we show ... Cited by 17 - Related articles - All 3 versions
